| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.07 |